Advocacy intelligence hub — real-time data for patient organizations
Protara Therapeutics — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Chief Scientific Operations Officer
Protara Therapeutics
Lydia Pathmanathan, MBBS, FRACP.
Principal Investigator
Stephen Luen, MBChB, FRACP.
Principal Investigator
Tony Penington, MBBS, FRACS.
Study Principal Investigator
Gamal El-Tagy, MD
pediatric surgery department, Cairo University
Imen Mehri Turki
University Hospital Mohamed Tahar Maamouri. Nabeul, Tunisia